Basic Information

EAGAN, MN, 55121-2410

Company Profile


Additional Details

Field Value
DUNS: 177980927
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: 75

  1. An immunomodulatory yeast-derived beta glucan as a component of a conjugate

    Amount: $149,450.00

    DESCRIPTION (provided by applicant): Fungal infections, particularly in immunocompromised patients, are a serious and growing problem. Although antifungal therapeutics have improved greatly, failures ...

    SBIR Phase I 2014 Department of Health and Human Services
  2. Evaluate Therapeutic Potential of Novel Immunomodulator, Imprime

    Amount: $159,140.00

    Pancreatic cancer is a "rare" and fata l disease, with few treatment options. Currently, promising antitumor strategies utilize combination therapies, with each agent targeting separate aspects of onc ...

    SBIR Phase I 2010 Department of Health and Human Services
  3. Oral beta-glucan treats hematopoietic injury resulting from acute radiation expos

    Amount: $139,136.00

    DESCRIPTION (provided by applicant): Biothera, Inc. has emerging scientific evidence that orally-administered whole glucan particle (WGP) ?- glucan produces potent immunologic and hematopoietic activi ...

    SBIR Phase I 2006 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government